BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1329232)

  • 1. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome.
    Bradley SJ; Weaver DW; Bouwman DL
    Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular carcinoma of the breast in situ and infiltrating.
    Wheeler JE; Enterline HT
    Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in the management of breast cancer. 1. Carcinoma in situ of the breast.
    Donegan WL
    Can J Surg; 1992 Aug; 35(4):361-5. PubMed ID: 1323379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of in situ cancer.
    Recht A; Connolly JL; Schnitt SJ; Harris JR
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Nolthenius-Puylaert MC; van der Heijden LH; Coebergh JW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):659-63. PubMed ID: 10774294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of carcinoma in situ of the breast].
    Raudrant D; Golfier F; Unger P
    Rev Fr Gynecol Obstet; 1990 Feb; 85(2):91-6. PubMed ID: 2157271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical implications of population screening for mammary carcinoma.
    Wobbes T
    Eur J Surg Oncol; 1990 Feb; 16(1):15-7. PubMed ID: 2155138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
    Hussain M; Cunnick GH
    Eur J Surg Oncol; 2011 Apr; 37(4):279-89. PubMed ID: 21306860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The familial carcinoma burden and indications for subcutaneous mastectomy].
    Müller A; Tschahargane C; Schmidt W
    Dtsch Med Wochenschr; 1989 Apr; 114(15):575-9. PubMed ID: 2539289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
    Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between core biopsy and excisional biopsy in breast high-risk lesions.
    Margenthaler JA; Duke D; Monsees BS; Barton PT; Clark C; Dietz JR
    Am J Surg; 2006 Oct; 192(4):534-7. PubMed ID: 16978969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.